Adjustments for anthropometric and other demographic variables were made where appropriate. Due to the low frequency of individuals homozygous for the T allele of rs1801725 (n = 207, 1.7%) and the C allele of rs3815148 (n = 637, 5.1%), dominant models were used for these polymorphisms in order to avoid the presentation of tables containing cells with very low frequencies in particular cohorts.

Additive models were used for rs2941740 and rs9594759 with genotypes coded as 0, 1 and 2 for the number of minor alleles. Likelihood ratio tests were used to compare the fit of the additive models compared with the full genotype model. find more For continuous traits, the normality of the standardised residuals was inspected with distributional diagnostic plots. For the harmonisation of continuous traits that were used to obtain pooled estimates of the genotypic effects, z-score units were calculated in each study by subtracting the study Obeticholic Acid mouse mean and dividing by its standard deviation. The overall mean for z-scores is 0 and standard deviation 1.

Two-step [55] meta-analyses using a random-effects model were performed to obtain pooled genotypic effects. The I2 measure was used to quantify heterogeneity [56]. Finally, the calculation of z-scores, for the continuous traits, and the main analyses were repeated in males and females separately. Reporting of the analyses met the appropriate items of recommended checklists [57] and [58]. A two-tailed significance level of p < 0.05 was used as evidence of statistical significance. Statistical analysis was performed in Stata 11.2 (StataCorp LP). A total of 12,836 adults aged between 52 and 90 + years had relevant genotypic and phenotypic data available (Table 1). Summaries of measures of body size and demographic characteristics are presented in Table S1. The call rates

were high, exceeding 93% across all studies for the four polymorphisms. The HWE condition was met in all studies for all polymorphisms (p > 0.08), except for rs9594759 (RANKL) in NSHD (p = 0.009) and CaPS (p = 0.04). Associations between the genotypes and anthropometric and demographic variables are Bumetanide presented in Tables S2–S4, showing no evidence for genotypic effects on any of the considered potential confounders for physical capability in the pooled analyses, except for alcohol consumption for rs9594759 (RANKL), with the C allele less common among frequent drinkers (p = 0.004, Fig. S1). Fig. 1, Fig. 2, Fig. 3 and Fig. 4 and Tables S5–S8 show the associations between the polymorphisms and measures of physical capability adjusted for age and sex. From the pooled analyses there was some evidence for an association between the T allele of rs1801725 (CASR) and poorer grip strength (p = 0.05).